Cancer News and Research

Latest Cancer News and Research

PCI Biotech rights issue oversubscribed

The Oslo-Axess-listed Norwegian biopharmaceutical company PCI Biotech Holding ASA today announced that it has raised NOK90 million through a new rights issue. The company received subscriptions for a total of approximately 3.36 million new shares. The initial offering was and remains 2,250,000 new shares, and the rights issue was thus oversubscribed by approximately 50 percent.

10 Jun 2010

Updated clinical data from SNSS's Phase 2 clinical trial of voreloxin

MicroStockProfit.com announces an investment report featuring Sunesis Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

10 Jun 2010

Preclinical data of VB-201 to be presented at EULAR Annual European Congress of Rheumatology

VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced the upcoming presentation of preclinical data from the company's lead program, VB-201, at the European League Against Rheumatism Annual European Congress of Rheumatology.

10 Jun 2010

Caregiver's guide on avoiding life-threatening swallowing problems

That's the message of Drs. Roya Sayadi and Joel Herskowitz. They are a wife-husband team from Natick, Massachusetts, who are spreading the word that swallowing problems are everywhere - and they can be deadly!

10 Jun 2010

Study to understand process of telomere shortening

A new study at the University of Leicester is examining a sequence of DNA- known as telomeres - that varies in length between individual.

10 Jun 2010

Investigative Workshop aims to discuss current achievements, challenges in modeling solid tumors

With high human mortality associated with cancerous tumors, there is a worldwide need for a better understanding of why a tumor starts to grow and what makes it continue to grow. Mathematical modeling can provide some of the answers.

10 Jun 2010

Spectrum Dynamics commences ultra low dose trials of radiopharmaceutical agents with D-SPECT technology

Cardiovascular imaging accounts for 30 percent of all the radiation patients receive in the U.S. and today, at the Society for Nuclear Medicine annual meeting, Spectrum Dynamics announced it has begun clinical studies to show that its D-SPECT™ technology can accommodate significantly lower doses of radiopharmaceutical agents so the total radiation exposure to patients and staff is much lower compared to conventional cardiac imaging.

10 Jun 2010

Study suggests potential of ARC man-made compound in combination with Abbott's ABT-737 for cancer

Adding a second agent may make a new, experimental anti-cancer drug effective against a wide range of cancers, researchers at the University of Illinois at Chicago College of Medicine have found.

10 Jun 2010

Aeterna Zentaris reports final results on clinical activity of perifosine for metastatic colorectal cancer

Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today reported final results on the clinical activity of perifosine (KRX-0401), the Company's novel, potentially first-in-class, oral anticancer agent that inhibits Akt activation in the phosphoinositide 3-kinase pathway, in combination with capecitabine (Xeloda) as a treatment for advanced, metastatic colorectal cancer.

10 Jun 2010

Study reveals insurance related differences in hospital mortality for AMI, stroke, pneumonia

An analysis of over 150,000 hospital discharges has revealed that there are significant insurance related differences in hospital mortality, length of stay, and costs among working-age Americans (age 18-64 years) hospitalized for acute myocardial infarction (AMI), stroke, or pneumonia. These three conditions are among the leading causes of non-cancer in-patient deaths in patients under 65 years old. The analysis is published today in the Journal of Hospital Medicine.

10 Jun 2010

Voices Against Brain Cancer's fifth annual gala to fight brain cancer

Voices Against Brain Cancer's fifth annual gala, Sounding Off For A Cure, to fight brain cancer. Proceeds from the event will benefit innovative brain cancer research programs at, Columbia, Cornell, Duke, Harvard, Memorial Sloan-Kettering, University of Michigan, University of Pittsburg and Brookhaven National Laboratory.

10 Jun 2010

Genzyme, Carl C. Icahn announce agreement to settle proxy contest

Genzyme Corporation and Carl C. Icahn and certain of his affiliated private investment funds announced today an agreement to settle their proxy contest.

10 Jun 2010

AASLD recommends surveillance in patients with cirrhosis who are at high risk of developing HCC

A study conducted by researchers at the Baylor College of Medicine found that fewer than 20% of patients with hepatocellular carcinoma preceded by cirrhosis were monitored for the development of cancer. Full findings of this study are published in the July issue of Hepatology, a journal of the American Association for the Study of Liver Diseases .

10 Jun 2010

People who smoke immediately after waking may be at risk for lung cancer: Study

People who smoke their first cigarette within minutes after waking up have much higher levels of cotinine, a by-product of nicotine when processed by the body, than those who wait to smoke, regardless of the number of cigarettes smoked.

10 Jun 2010

Driving while distracted is equivalent to drunken driving

It's time for physicians to talk to patients about driving while distracted, a problem that has risen to the rough equivalence of drunken driving thanks to the proliferation of phones that allow drivers to talk and text, Amy Ship, MD, a primary care physician at Beth Israel Deaconess Medical Center suggests.

10 Jun 2010

Free education program highlights advancements in treatment of blood cancers, importance of clinical trials

The John Theurer Cancer Center at Hackensack University Medical Center and The Leukemia & Lymphoma Society have come together to host Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers on Tuesday, June 22 in Hackensack, NJ. This free educational program is for patients, caregivers, and healthcare providers.

10 Jun 2010

Protagen, Bayer Schering Pharma close cooperation contract for biomarker discovery in Endometriosis

Protagen AG, a specialist for in-vitro diagnostics and GMP-compliant protein analysis, and Bayer Schering Pharma AG, a global leading specialty pharmaceuticals company, announced today the closing of a cooperation contract for discovery of novel biomarkers in Endometriosis.

10 Jun 2010

Emergency hospital admissions for heart attacks drop by 2.4% following smoke-free legislation

The introduction of smoke-free legislation in England was followed by a 2.4 per cent drop in the number of emergency hospital admissions for heart attacks, new research shows.

10 Jun 2010

TF2 bispecific antibody pretargeted therapy prolongs survival in animal model of human colonic cancer

Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that pretargeted therapy with TF2, a bispecific antibody against carcinoembryonic antigen (CEA) and a small peptide, delayed tumor growth and prolonged survival in an animal model of human colonic cancer.

10 Jun 2010

ExonHit to pay $12.5M in cash and $10M in stock for RedPath Integrated Pathology acquisition

The extraordinary shareholders' meeting of convened to approve the acquisition of the US company, RedPath Integrated Pathology, will be held on first notice, on Monday, June 28, 2010 at 17:30 CET, at the Company's headquarters, 63-65 boulevard Masséna, 75013 Paris, France. If the quorum is not met, the meeting will be held, on second notice, on July 8, 2010, at 16:00 CET, at the Company's headquarters.

10 Jun 2010

Cancer News and Research

Latest Cancer News and Research

PCI Biotech rights issue oversubscribed

Updated clinical data from SNSS's Phase 2 clinical trial of voreloxin

Preclinical data of VB-201 to be presented at EULAR Annual European Congress of Rheumatology

Caregiver's guide on avoiding life-threatening swallowing problems

Study to understand process of telomere shortening

Investigative Workshop aims to discuss current achievements, challenges in modeling solid tumors

Spectrum Dynamics commences ultra low dose trials of radiopharmaceutical agents with D-SPECT technology

Study suggests potential of ARC man-made compound in combination with Abbott's ABT-737 for cancer

Aeterna Zentaris reports final results on clinical activity of perifosine for metastatic colorectal cancer

Study reveals insurance related differences in hospital mortality for AMI, stroke, pneumonia

Voices Against Brain Cancer's fifth annual gala to fight brain cancer

Genzyme, Carl C. Icahn announce agreement to settle proxy contest

AASLD recommends surveillance in patients with cirrhosis who are at high risk of developing HCC

People who smoke immediately after waking may be at risk for lung cancer: Study

Driving while distracted is equivalent to drunken driving

Free education program highlights advancements in treatment of blood cancers, importance of clinical trials

Protagen, Bayer Schering Pharma close cooperation contract for biomarker discovery in Endometriosis

Emergency hospital admissions for heart attacks drop by 2.4% following smoke-free legislation

TF2 bispecific antibody pretargeted therapy prolongs survival in animal model of human colonic cancer

ExonHit to pay $12.5M in cash and $10M in stock for RedPath Integrated Pathology acquisition

Industry Focus: Cell & Gene Therapy eBook

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Cancer News and Research

Latest Cancer News and Research

Industry Focus: Cell & Gene Therapy eBook

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Newsletters you may be interested in